Eversense 365 is the world’s first and only one year CGM, which was approved by the United States (US) Food and Drug Administration in September of 2024 and launched across the country in October of ...
Unlike in the U.S., European clearance requires audit steps driven by a third party known as the notified body. BSI Group will be the notified body for Modular Medical’s CE mark process, determining ...
Intensive Training Course on Pre- and Post-Market StudiesDublin, Feb. 05, 2025 (GLOBE NEWSWIRE) -- The "Medical Device Studies: Clinical Evidence Training Course (ONLINE EVENT: April 7-8, 2025)" has ...